BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8945626)

  • 1. Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway.
    Wang QJ; Knezetic JA; Schally AV; Pour PM; Adrian TE
    Int J Cancer; 1996 Nov; 68(4):528-34. PubMed ID: 8945626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRP-receptor-mediated signal transduction, gene expression and DNA synthesis in the human pancreatic adenocarcinoma cell line HPAF.
    Burghardt B; Wenger C; Barabás K; Rácz G; Oláh A; Flautner L; Coy DH; Gress TM; Varga G
    Peptides; 2001 Jul; 22(7):1119-28. PubMed ID: 11445243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptors and ligands for autocrine growth pathways are up-regulated when pancreatic cancer cells are adapted to serum-free culture.
    Murphy LO; Abdel-Wahab YH; Wang QJ; Knezetic JA; Permnert J; Larsson J; Hollingsworth AM; Adrian TE
    Pancreas; 2001 Apr; 22(3):293-8. PubMed ID: 11291932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
    Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
    Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation.
    Ryder NM; Guha S; Hines OJ; Reber HA; Rozengurt E
    J Cell Physiol; 2001 Jan; 186(1):53-64. PubMed ID: 11147814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
    Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro.
    Qin Y; Ertl T; Cai RZ; Halmos G; Schally AV
    Cancer Res; 1994 Feb; 54(4):1035-41. PubMed ID: 8313359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
    Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
    Narayan S; Spindel ER; Rubin NH; Singh P
    Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of growth of experimental human and hamster pancreatic cancers in vivo by a targeted cytotoxic bombesin analog.
    Szepeshazi K; Schally AV; Nagy A; Halmos G
    Pancreas; 2005 Oct; 31(3):275-82. PubMed ID: 16163060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of mRNA for gastrin-releasing peptide receptor by human bronchial epithelial cells. Association with prolonged tobacco exposure and responsiveness to bombesin-like peptides.
    Siegfried JM; DeMichele MA; Hunt JD; Davis AG; Vohra KP; Pilewski JM
    Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):358-66. PubMed ID: 9279210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bombesin receptors in a human duodenal tumor cell line: binding properties and function.
    Williams BY; Schonbrunn A
    Cancer Res; 1994 Feb; 54(3):818-24. PubMed ID: 8306345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
    Szepeshazi K; Schally AV; Cai RZ; Radulovic S; Milovanovic S; Szoke B
    Cancer Res; 1991 Nov; 51(21):5980-6. PubMed ID: 1682039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer.
    Siegfried JM; Krishnamachary N; Gaither Davis A; Gubish C; Hunt JD; Shriver SP
    Pulm Pharmacol Ther; 1999; 12(5):291-302. PubMed ID: 10545285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
    Thomas F; Arvelo F; Antoine E; Jacrot M; Poupon MF
    Cancer Res; 1992 Sep; 52(18):4872-7. PubMed ID: 1325285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of p53 protein expression and cellular localization in human and hamster pancreatic cancer cell lines.
    Mogaki M; Hirota M; Chaney WG; Pour PM
    Carcinogenesis; 1993 Dec; 14(12):2589-94. PubMed ID: 8269631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of proliferation and migration of a colorectal cancer cell line by amidated and glycine-extended gastrin-releasing peptide via the same receptor.
    Patel O; Dumesny C; Giraud AS; Baldwin GS; Shulkes A
    Biochem Pharmacol; 2004 Dec; 68(11):2129-42. PubMed ID: 15498503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR.
    Ramachandran V; Arumugam T; Hwang RF; Greenson JK; Simeone DM; Logsdon CD
    Cancer Res; 2007 Mar; 67(6):2666-75. PubMed ID: 17363587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
    Zhu Z; Kleeff J; Kayed H; Wang L; Korc M; Büchler MW; Friess H
    Mol Carcinog; 2002 Nov; 35(3):138-47. PubMed ID: 12410565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth effects of regulatory peptides and intracellular signaling routes in human pancreatic cancer cell lines.
    Douziech N; Lajas A; Coulombe Z; Calvo E; Lainé J; Morisset J
    Endocrine; 1998 Oct; 9(2):171-83. PubMed ID: 9867251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.